Status:
UNKNOWN
Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands
Lead Sponsor:
Ballad Health
Conditions:
Cancer Colon
Eligibility:
All Genders
45-84 years
Phase:
NA
Brief Summary
This is a prospective implementation study that will include patients that are identified as being average risk for colorectal cancer (CRC) according to USPSTF guidelines and who have opted to be scre...
Detailed Description
Study Rationale This is a prospective implementation study that will include patients that are identified as being average risk for colorectal cancer (CRC) according to USPSTF guidelines and who have ...
Eligibility Criteria
Inclusion
- Patients aged 45-84 years of age (inclusive)
- Considered by health-care providers to be "average risk" for CRC as determined by USPSTF guidelines
- If a patient opts for blood-based test, they are able and willing to provide blood samples per protocol
- Ability to understand and the willingness to participate in the study
Exclusion
- Patients with a personal history of CRC
- Patients with a known high-risk family history of CRC precluding the patient from being average risk
- Patients with known diagnosis of inflammatory bowel disease or history of polyps
- Patients who are currently symptomatic for CRC such as: blood in the stool
- Patients with any known medical condition which, in the opinion of the investigator, should preclude enrollment into the study
- Have a recorded up to date CRC screening
- Patients with a previous abnormal colonoscopy finding who are due for surveillance.
Key Trial Info
Start Date :
October 12 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2024
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06119425
Start Date
October 12 2023
End Date
October 31 2024
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johnson City Medical Center
Johnson City, Tennessee, United States, 37604